A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart. Sanofi ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs. First ...

If your body doesn't make enough insulin (a hormone in your body that helps regulate your blood sugar) or stops responding to it, you may need to take prescription insulin. Taking insulin regularly ...

Dear Toni: Currently, I am on a stand-alone Part D plan with a Medicare supplement because of my serious health issues. Last week, I received information about the 2026 changes to the Medicare Part D ...

This Phase 3 clinical trial on BioChaperone® Lispro (THDB0206 injection) conducted in China in people with Type 1 Diabetes, successfully demonstrated, in comparison with standard of care Humalog®: Non ...

TEMPO.CO, Jakarta - The management of PT Krakatau Steel (Persero) Tbk has submitted a working capital of US$500 million, or Rp8.3 trillion (at an exchange rate of Rp16,602 per U.S. dollar) to the Daya ...

At the HOT ROD How-To section, you’ll learn how to make improvements to your own special hot rod, drawing from the DIY knowledge of the HOT ROD team to learn more about how-to make more power from ...